Tag: Home Feature
Before he set out to understand how tens of thousands of genes are behaving in breast cancer, Charles M. Perou, PhD, was hunting just one gene. As a graduate student at the University of Utah in the 1990s, Perou was focused on finding the genetic cause of a rare and fatal inherited genetic disorder that … Continued
Jack Goldstein, 14, and his family had to make sacrifices when Jack was diagnosed with leukemia. But when Jack put his schoolwork and baseball training on hold, his family and friends were there to support him, first emotionally, and then by helping raise funds for UNC Lineberger, where he was being treated for cancer.
Once cancer treatment ends, hopefully with a clean bill of health, most patients hightail it away from the hospital, putting the endless batteries of tests, needle sticks and scans in their rearview mirror. So it’s a rare patient that returns of their own volition, and rarer still, becomes a lab volunteer. But that’s exactly what David Hesmer did.
Bill and Nancy Graham of Winston-Salem, North Carolina, have donated $1 million to support breast cancer research and care at the UNC Lineberger Comprehensive Cancer Center. The Grahams established the Bill and Nancy Graham Breast Cancer Research Fund to provide the cancer center’s leadership with unrestricted funding, which enables them to make investments where the … Continued
For Matthew Milowsky, MD, the George Gabriel and Frances Gable Villere Distinguished Professor of Bladder and Genitourinary Cancer Research, the why of genitourinary cancers is just as important to him as the how and what. As a former philosophy major, it’s natural that the questions behind these cancers are what drive the clinician and researcher to explore new methods to treat and care for patients.
Preliminary results from a University of North Carolina Lineberger Comprehensive Cancer Center study found that just 15 percent of a group of men in North Carolina with early-stage prostate cancer who choose active surveillance instead of treatment followed the recommended monitoring guidelines. The findings, which were presented today at the American Society of Clinical Oncology … Continued
University of North Carolina Lineberger Comprehensive Cancer Center researchers have uncovered the mechanism that explains how an investigational cancer therapeutic might be working – a finding that they believe could be important for the design of potential new therapies. In the journal ACS Chemical Biology, researchers explain how the investigational compound ONC201 may be working … Continued